- Previous Close
37.38 - Open
37.42 - Bid 38.22 x --
- Ask 38.26 x --
- Day's Range
37.42 - 38.34 - 52 Week Range
37.20 - 64.80 - Volume
2,443,761 - Avg. Volume
4,238,332 - Market Cap (intraday)
26.204B - Beta (5Y Monthly) -0.15
- PE Ratio (TTM)
11.73 - EPS (TTM)
3.26 - Earnings Date Oct 25, 2024 - Oct 29, 2024
- Forward Dividend & Yield 1.18 (3.16%)
- Ex-Dividend Date Jun 5, 2024
- 1y Target Est
--
EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S., together with subsidiaries, engages in health and real estate development businesses primarily in Turkey. The Health segment produces and sells human health and veterinary drugs, as well as engages in pharmaceutical sales and marketing. The Real Estate Development segment develops real estate properties; engages in leasing activities for facilities; and provides consulting services regarding land development and project management. The company was incorporated in 1951 and is based in Istanbul, Turkey. EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. is a subsidiary of Eczacibasi Holding A.S.
www.eis.com.tr1,122
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: ECILC.IS
View MorePerformance Overview: ECILC.IS
Trailing total returns as of 10/22/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ECILC.IS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ECILC.IS
View MoreValuation Measures
Market Cap
25.62B
Enterprise Value
27.36B
Trailing P/E
11.47
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.34
Price/Book (mrq)
0.60
Enterprise Value/Revenue
4.64
Enterprise Value/EBITDA
7.58
Financial Highlights
Profitability and Income Statement
Profit Margin
37.90%
Return on Assets (ttm)
-0.08%
Return on Equity (ttm)
7.24%
Revenue (ttm)
5.9B
Net Income Avi to Common (ttm)
2.24B
Diluted EPS (ttm)
3.26
Balance Sheet and Cash Flow
Total Cash (mrq)
1.58B
Total Debt/Equity (mrq)
7.78%
Levered Free Cash Flow (ttm)
-1.36B